Related Experiment Video
Updated: Aug 16, 2026
12:09
Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Anandamide and vanilloid TRPV1 receptors
1Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland. r.ross@abdn.ac.uk
British Journal of Pharmacology
|October 1, 2003
Summary
Anandamide, an endocannabinoid, activates TRPV1 receptors, acting as a partial or full agonist depending on tissue conditions. This interaction has implications for treating inflammatory and cardiovascular disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- The endocannabinoid anandamide is known to activate TRPV1 receptors.
- Anandamide's efficacy as a TRPV1 agonist is context-dependent, varying with receptor reserve and physiological conditions.
Purpose of the Study:
- To elucidate the mechanisms and implications of anandamide's activation of TRPV1 receptors.
- To explore the role of the endocannabinoid system in modulating TRPV1 receptor activity.
Main Methods:
- Review of existing scientific literature on anandamide and TRPV1 receptor interactions.
- Analysis of factors influencing anandamide's agonist efficacy.
Main Results:
- Anandamide acts as a low intrinsic efficacy TRPV1 agonist, functioning as a partial agonist in low receptor reserve tissues and a full agonist in high receptor reserve tissues or disease states.
- Anandamide's efficacy is modulated by factors including receptor reserve, phosphorylation, metabolism, uptake, CB1 receptor activation, voltage, temperature, pH, and bovine serum albumin.
- Evidence suggests the endocannabinoid system modulates TRPV1 receptor activation by anandamide.
Conclusions:
- Anandamide's activation of TRPV1 receptors presents potential therapeutic avenues for inflammatory, respiratory, and cardiovascular disorders.
- Further research is needed to determine anandamide's precise physiological and pathophysiological role as a TRPV1 receptor agonist compared to other candidates.
Related Concept Videos
01:43Thermosensation
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
01:12Mechanically-gated Ion Channels
Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...